-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FVahY66kuOSC7BP2LPIAAdlDPlKFiACav6USgJWw52p8dHwNUU5fmMm+2JHTNGY+ q9mHq3iAX1yhsWphsczjvg== 0001295345-05-000052.txt : 20051018 0001295345-05-000052.hdr.sgml : 20051018 20051018160232 ACCESSION NUMBER: 0001295345-05-000052 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051018 ITEM INFORMATION: Termination of a Material Definitive Agreement FILED AS OF DATE: 20051018 DATE AS OF CHANGE: 20051018 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 133808303 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12584 FILM NUMBER: 051143032 BUSINESS ADDRESS: STREET 1: 1220 GLENMORE DRIVE CITY: APOPKA STATE: FL ZIP: 32712 BUSINESS PHONE: 407-880-2213 MAIL ADDRESS: STREET 1: 1220 GLENMORE DRIVE CITY: APOPKA STATE: FL ZIP: 32712 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19940606 8-K 1 sfph.htm CURRENT REPORT ON FORM 8-K SFPH

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________

FORM 8-K
___________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (date of earliest event reported): October 17, 2005

 
SHEFFIELD PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in its Charter)

 

Commission File No.: 01-12584

 

Delaware

               

13-3808303

(State of Incorporation)

               

(I.R.S. Employer Identification No.)

 

                              

1220 Glenmore Drive Apopka, FL

               

32712

(Address Of Principal Executive Offices)

               

(ZIP Code)

 

REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (407) 880-2213

 

 

 



ITEM 1.02 TERMINATION OF A MATERIAL DEFINITIVE AGREEMENT Back to Table of Contents

Sheffield Pharmaceuticals, Inc., a Delaware corporation, is sometimes referred to herein as "we", "us", "our", "Company" and the "Registrant". On October 3, 2005, the Registrant executed a Letter of Intent to acquire PremierBPO, Inc. ("Premier"). On October 17, 2005, the Registrant and Premier mutually agreed to terminate the Letter of Intent.

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

/s/ Michael F. Manion
Michael F. Manion
  CEO, CFO and Chairman of the Board
  Date: October 18, 2005

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----